A prospective trial of U500 insulin delivered by Omnipod in patients with type 2 diabetes mellitus and severe insulin resistance

Endocrine Practice

Volumn 16, Issue 5, 2010, Pages 778-784

  Lane, Wendy S ^a   Weinrib, Stephen L ^a   Rappaport, Jonathan M ^a   Przestrzelski, Therese ^a  

^a Mountain Diabetes and Endocrine Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; HUMAN INSULIN; PIG INSULIN; U 500; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BLOOD GLUCOSE MONITORING; CLINICAL ARTICLE; CLINICAL TRIAL; CONTINUOUS INFUSION; CONTROLLED STUDY; DIABETIC PATIENT; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG SAFETY; DRUG SUBSTITUTION; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; FEMALE; HUMAN; INSULIN RESISTANCE; INSULIN TREATMENT; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PROSPECTIVE STUDY;

ADULT; AGED; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; DOSAGE FORMS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN INFUSION SYSTEMS; INSULIN RESISTANCE; MALE; MIDDLE AGED;

EID: 78149329097     PISSN: 1530891X     EISSN: None     Source Type: Journal    
DOI: 10.4158/EP10014.OR     Document Type: Article

References (18)

1. Lane WS, Cochran EK, Jackson JA, et al. High-dose insulin therapy: Is it time for U-500 insulin? Endocr Pract. 2009;15:71-79.
2. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) (erratum in Lancet. 1999;354:602).
3. Lancet. 1998;352:837-853.
4. Ohkubo Y, Kishikawa H, Araki E, et al. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: A randomized, prospective 6-year study. Diabetes Res Clin Pract. 1995;28:103-117.
5. Peyrot M, Rubin RR. Validity and reliability of an instrument for assessing health-related quality of life and treatment preferences: The Insulin Delivery System Rating Questionnaire. Diabetes Care. 2005;28:53-58.
6. Wainstein J, Metzger M, Boaz M, et al. Insulin pump therapy vs. multiple daily injections in obese type 2 diabetic patients. Diabet Med. 2005;22:1037-1046.
7. Berthe E, Lireux B, Coffin C, et al. Effectiveness of intensive insulin therapy by multiple daily injections and continuous subcutaneous insulin infusion: A comparison study in type 2 diabetes with conventional insulin regimen failure. Horm Metab Res. 2007;39:224-229.
8. Edelman S, Bode B, Bailey T, Kipnes M, Frias J. Continuous subcutaneous insulin infusion in patients with type 2 diabetes safely improved glycemic control using a simple insulin dosing regimen. Presented at the American Diabetes Association Meeting; June 2009; New Orleans, LA. Abstract 428-P.
9. Raskin P, Bode BW, Marks JB, et al. Continuous subcutaneous insulin infusion and multiple daily injection therapy are equally effective in type 2 diabetes: A randomized, parallel-group, 24-week study. Diabetes Care. 2003;26:2598-2603.
10. Herman WH, Ilag LL, Johnson SL, et al. A clinical trial of continuous subcutaneous insulin infusion versus multiple daily injections in older adults with type 2 diabetes. Diabetes Care. 2005;28:1568-1573.
11. Davidson MB, Navar MD, Echeverry D, Duran P. U-500 regular insulin: Clinical experience and pharmacokinetics in obese, severely insulin-resistant type 2 diabetic patients. Diabetes Care. 2010;33:281-283.
12. Knee TS, Seidensticker DF, Walton JL, Solberg LM, Lasseter DH. A novel use of U-500 insulin for continuous subcutaneous insulin infusion in patients with insulin resistance: A case series. Endocr Pract. 2003;9:181-186.
13. Lane WS. Use of U-500 regular insulin by continuous subcutaneous insulin infusion in patients with type 2 diabetes and severe insulin resistance. Endocr Pract. 2006;12:251-256.
14. Genuth S. Insulin use in NIDDM. Diabetes Care. 1990;13:1240-1264.
15. Henry RR, Gumbiner B, Ditzler T, Wallace P, Lyon R, Glauber HS. Intensive conventional insulin therapy for type II diabetes. Metabolic effects during a 6-mo outpatient trial. Diabetes Care. 1993;16:21-31.
16. Yki-Järvinen H, Kauppila M, Kujansuu E, et al. Comparison of insulin regimens in patients with non-insulin-dependent diabetes mellitus. N Engl J Med. 1992;327:1426-1433.
17. Cochran E. U500-insulin: When more with less yields success. Diabetes Spectr. 2009;22:116-122.
18. Drugstore.com Web site. Available at http://www.drugstore.com. Accessed December, 2009.